A downgrade of its financial guidance for the full year, in addition to a few preliminary third quarter figures, has taken some of the excitement out of GN Hearing's upcoming release of the third quarterly report for 2021.
Still, investors will look for more information concerning the downgrade, with GN Hearing at its center.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Scientific Writer 
Senior IT Network Engineer 
Nordic Medical Affairs Manager 
Clinical Trial Administrator 
Account Manager 
Innovation Project Manager, Display Unit 
(Senior) Drug Substance Specialist 
Project Manager & Scrum Master 
Clinical Trial Manager 
Senior Chemical Safety Advisor 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Clinical Trial Manager for development of in vitro diagnostics 
IRT Manager, Clinical Drug Supply 
Director for innovative pre-clinical testing unit 
Key Account Manager, Europe and Asia 
Senior Project Manager (GMP - Life Science)